Negative regulation of bcl-2 expression by p53 in hematopoietic cells

Oncogene
Y WuLinda M Boxer

Abstract

The p53 protein activates promoters containing p53 binding sites, and it represses other promoters. We examined the effect of p53 on bcl-2 expression in both the DHL-4 B cell line and the K562 erythroleukemia line. Transient transfection analyses revealed that wild-type p53 repressed the bcl-2 full-length promoter. The region of the bcl-2 promoter that was responsive to p53 was mapped to the bcl-2 P2 minimal promoter region, and we showed that p53 and the TATA binding protein bound to the bcl-2 TATA sequence. The TATA binding protein, p53, histone deacetylase-1 and mSin3a could be co-immunoprecipitated from K562 cell nuclear extract. The TATA binding protein and mSin3a could be recovered in a complex at the bcl-2 promoter TATA sequence, however, the formation of this complex was not dependent on the presence of p53. Treatment of K562 cells with the histone deacetylase inhibitor, trichostatin A, resulted in an increase in bcl-2 promoter activity whether p53 was present or not. Therefore, we demonstrated that p53 and the histone deacetylases repress the bcl-2 promoter independently. Similar results were obtained when endogenous bcl-2 mRNA or protein levels were measured in response to either p53 or trichostatin A, and p53 express...Continue Reading

References

Aug 1, 1992·Journal of Virology·M A SublerS Deb
Mar 1, 1992·The Journal of Pathology·R VilluendasP Martinez
Nov 1, 1992·Journal of Clinical Pathology·Y SoiniK Vähäkangas
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·E SetoT Shenk
Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·N AoyamaS Ishii
Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y ShiioN Yamaguchi
Jan 1, 1991·Applied Biochemistry and Biotechnology·O F WebbG S Sayler
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D GinsbergM Oren
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·Y Tsujimoto, C M Croce
Jan 8, 1987·The New England Journal of Medicine·J J YunisM Arnesen
Jul 1, 1995·Molecular and Cellular Biology·H M Chen, L M Boxer
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y Shen, T Shenk
Dec 16, 1993·Nature·Y XiongD Beach
May 1, 1996·American Journal of Clinical Pathology·P L NguyenN L Harris
May 1, 1996·Genes & Development·L J Ko, C Prives
Jun 7, 1996·Biochimica Et Biophysica Acta·T M Gottlieb, M Oren
Jul 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H KramerP M Kluin
Nov 1, 1996·The Journal of Pathology·M IlyasN Rooney
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·K K Walker, A J Levine
May 1, 1996·Leukemia & Lymphoma·T WatanabeT Hotta

❮ Previous
Next ❯

Citations

Jan 26, 2007·Apoptosis : an International Journal on Programmed Cell Death·M A Christine PrattMin Ying Niu
Mar 11, 2006·Apoptosis : an International Journal on Programmed Cell Death·M LauricellaG Tesoriere
Sep 21, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Christopher BlackmoreAru Narendran
Jun 1, 2005·Biochemical and Biophysical Research Communications·Ryungsa Kim
Feb 5, 2013·Plasmid·Marianna RodovaM Rafiq Islam
Sep 24, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Hanna PiotrowskaJadwiga Jodynis-Liebert
Dec 4, 2001·Advanced Drug Delivery Reviews·Y S Haviv, D T Curiel
Mar 20, 2002·Biochimie·D P Guimaraes, P Hainaut
Dec 4, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Clare Henderson, Claudio Brancolini
Mar 22, 2002·Mutation Research·Suzanne M Morris
Nov 17, 2009·Journal of the American Chemical Society·Samantha KendrickLaurence H Hurley
Sep 25, 2009·Nature Reviews. Cancer·Shirley Polager, Doron Ginsberg
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Liang QiaoPaul Dent
Jan 30, 2013·The Journal of Experimental Medicine·Sankaranarayanan KannanPatrick A Zweidler-McKay
Apr 2, 2005·Viral Immunology·Katarzyna A PirógHanna B Rokita
Dec 18, 2012·Briefings in Functional Genomics·Justin A Freeman, Joaquin M Espinosa
Jan 30, 2010·International Journal of Cell Biology·Nadia Gabellini, Valentina Masola
Oct 26, 2011·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Dong ChenKejun Zhang
Jun 5, 2008·The Journal of Clinical Investigation·Avi Ashkenazi, Roy S Herbst
Jul 23, 2011·Genes & Cancer·Marie P Khoury, Jean-Christophe Bourdon
Oct 17, 2008·BMC Genomics·Lukas VrbaBernard W Futscher
Jun 3, 2010·Frontiers in Bioscience (Landmark Edition)·Vita M Golubovskaya, William Cance
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Shulin Wang, Wafik S El-Deiry
Mar 26, 2011·Journal of Biomedicine & Biotechnology·Levin Böhlig, Karen Rother
Jun 26, 2014·Cell and Tissue Research·Judit VargaJózsef Szeberényi

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis